Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Evaluating the Homogeneity of the PSP ‐ RS Syndrome beyond Core Features
Kumar, Mahesh , Brewer, Benjamin, Ali, Farwa , Clark, Heather M. , Stierwalt, Julie A. G., Stephens, Yehkyoung C. , Savica, Rodolfo , Whitwell, Jennifer L. , Josephs, Keith A. , Stierwalt, Julie, Whitwell, Jennifer , Josephs, Keith A , Clark, Heather M , Brewer, Benjamin C. , Dickson, Dennis W.

Movement Disorders Clinical Practice | May 19, 2025 | Volume: 12 | Issue: 10 | Pages: 1560-1570

10.1002/mdc3.70134 | PMID 40384451 Get It

Abstract Background Classic progressive supranuclear palsy RS syndrome (PSP‐RS) is characterized by early postural instability/falls and vertical supranuclear gaze palsy, although other signs/symptoms can occur, for example, axial rigidity, bradykinesia, and cognitive dysfunction. The Movement Disorders Society‐PSP (MDS‐PSP) criteria consider probable PSP‐RS a homogenous syndrome, but this has not been tested. Objectives We aim to investigate relationships between signs/symptoms of PSP‐RS beyond its core features and determine whether PSP‐RS is a homogeneous syndrome. Methods 118 participants who met MDS‐PSP criteria for probable PSP‐RS were analyzed. All participants received an independent clinical diagnosis based on clinical judgment. We first performed a Network Analysis using qgraph with Spearman's correlation to quantify relationships between 16 signs/symptoms followed by a k‐means clustering analysis using the same signs/symptoms to identify possible heterogeneity of the PSP‐RS designation. Results Five network clusters were identified, reflecting: (1) tremor, (2) sensitivity to bright light, (3) oculomotor function, (4) cognition, and (5) akinetic‐rigidity‐praxis. Worse akinetic‐rigidity was associated with better oculomotor function, but worse cognition. Cluster analysis revealed two clusters. Cluster I ( n = 89) had more severe clinical features than Cluster II ( n = 29). Cluster II had a higher frequency of participants (37.9%) clinically judged as not PSP‐RS: these participants were less likely to have PSP pathology on autopsy ( P = 0.03). Conclusions Some signs/symptoms of PSP‐RS strongly associate and are more likely to co‐occur. PSP‐RS, as defined by the MDS‐PSP criteria includes a subset of participants not clinically judged as PSP‐RS who are less likely to have PSP pathology.
Continuation Versus Interruption of Oral Anticoagulation During TAVI: A Systematic Review and Meta‐Analysis Oral Anticoagulation Management in TAVI
Martins, Jefferson Manoel Borges , Borges, Rafael dos Santos , Berton, Giovanni Gosch , Vieira, Paula Larissa Ferreira, Sousa, Pedro Antônio Machado Gomes de , Vieira, Ana Livia Chaves , Fukunaga, Christian Ken , Vizentin, Vanessa Karlinski , Macêdo, E., Guida, Camila Mota , Borges Martins, Jefferson Manoel , Dos Santos Borges, Rafael , Gosch Berton, Giovanni , Ferreira Vieira, Paula Larissa , Machado Gomes de Sousa, Pedro Antônio , Chaves Vieira, Ana Livia , Ken Fukunaga, Christian , Karlinski Vizentin, Vanessa , Rodrigues Macedo, Esthefani Monique

Catheterization and Cardiovascular Interventions | May 19, 2025 | Volume: 106 | Issue: 1 | Pages: 644-653

10.1002/ccd.31599 | PMID 40384343 Get It

ABSTRACT Patients undergoing transcatheter aortic valve implantation (TAVI) often require long‐term oral anticoagulation (OAC), but it is unclear whether to continue or interrupt OAC during the procedure. This meta‐analysis compares clinical outcomes of continuing versus interrupting OAC during TAVI. PubMed, Embase, and Cochrane Central databases were searched from inception to September 2024 for studies comparing continuation versus interruption of OAC in patients undergoing TAVI with an indication for OAC, including vitamin K antagonists and direct oral anticoagulants. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using a random‐effects model. Sensitivity analysis was performed using the Hartung‐Knapp‐Sidik‐Jonkman method. Three studies were included, one randomized controlled trial and two cohort studies, with 2773 patients, of whom 1314 (47.4%) continued OAC during TAVI. At a 30‐day follow‐up after TAVI, there were no significant differences between groups in all‐cause mortality (RR 0.74; 95% CI 0.45–1.20; p = 0.22), any bleeding (RR 1.08; 95% CI 0.81–1.43; p = 0.60), and major bleeding (RR 0.90; 95% CI 0.67–1.21; p = 0.48). However, the continued OAC group was associated with a lower stroke rate (RR 0.65; 95% CI 0.42–1.01; p = 0.053), also attested after a sensitivity analysis (RR 0.65; 95% CI 0.47–0.90; p < 0.03). In patients with an indication for OAC undergoing TAVI, uninterrupted anticoagulation is associated with similar thrombotic and hemorrhagic outcomes compared to interrupted OAC. Stroke risk was lower in the continued OAC group, with a significant reduction, as demonstrated in sensitivity analysis.
Federated Learning for Renal Tumor Segmentation and Classification on Multi‐Center MRI Dataset
Nguyen, Dat‐Thanh , Imami, Maliha , Zhao, Linmei , Wu, Jing , Borhani, Ali , Khunte, Mihir , Zhong, Zhusi , Shi, Victoria, Yao, Sophie, Wang, Yuli , Loizou, Nicolas , Silva, Alvin C. , Zhang, Paul J. , Zhang, Zishu , Kamel, Ihab R. , Liao, Weihua , Bai, Harrison X. , Bai, Harrison X. , Kamel, Ihab R , Mohseni, Alireza , Yao, Sophie, Jiao, Zhicheng

Journal of Magnetic Resonance Imaging | May 19, 2025 | Volume: 62 | Issue: 3 | Pages: 814-824

10.1002/jmri.29819 | PMID 40384349 Get It

ABSTRACTBackgroundDeep learning (DL) models for accurate renal tumor characterization may benefit from multi‐center datasets for improved generalizability; however, data‐sharing constraints necessitate privacy‐preserving solutions like federated learning (FL).PurposeTo assess the performance and reliability of FL for renal tumor segmentation and classification in multi‐institutional MRI datasets.Study TypeRetrospective multi‐center study.PopulationA total of 987 patients (403 female) from six hospitals were included for analysis. 73% (723/987) had malignant renal tumors, primarily clear cell carcinoma (n = 509). Patients were split into training (n = 785), validation (n = 104), and test (n = 99) sets, stratified across three simulated institutions.Field Strength/SequenceMRI was performed at 1.5 T and 3 T using T2‐weighted imaging (T2WI) and contrast‐enhanced T1‐weighted imaging (CE‐T1WI) sequences.AssessmentFL and non‐FL approaches used nnU‐Net for tumor segmentation and ResNet for its classification. FL‐trained models across three simulated institutional clients with central weight aggregation, while the non‐FL approach used centralized training on the full dataset.Statistical TestsSegmentation was evaluated using Dice coefficients, and classification between malignant and benign lesions was assessed using accuracy, sensitivity, specificity, and area under the curves (AUCs). FL and non‐FL performance was compared using the Wilcoxon test for segmentation Dice and Delong's test for AUC (p < 0.05).ResultsNo significant difference was observed between FL and non‐FL models in segmentation (Dice: 0.43 vs. 0.45, p = 0.202) or classification (AUC: 0.69 vs. 0.64, p = 0.959) on the test set. For classification, no significant difference was observed between the models in accuracy (p = 0.912), sensitivity (p = 0.862), or specificity (p = 0.847) on the test set.Data ConclusionFL demonstrated comparable performance to non‐FL approaches in renal tumor segmentation and classification, supporting its potential as a privacy‐preserving alternative for multi‐institutional DL models.Evidence Level4.Technical EfficacyStage 2.
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial
Kelley, Robin Kate , Reig, María , Lim, Ho Yeong , Toni, Enrico N. De , Mody, Kabir , Crysler, Oxana , Lipatov, Oleg , Morimoto, Manabu , Archambeaud, Isabelle , Burgio, Valentina , Phuong, Le Thi Tuyet, Ko, Yoo‐Joung, Ran, Di , Makowsky, Mallory, Negro, Alejandra , De Toni, Enrico N , Reig, Maria , Lau, George , Sangro, Bruno , Cheng, Ann‐Lii , Kudo, Masatoshi , Tak, Won Young , Gasbarrini, Antonio , Tougeron, David , Tam, Vincent C. , Gong, Jun , Sukeepaisarnjaroen, Wattana , Chao, Yee , Péron, Jean‐Marie , Berres, Marie‐Luise , Ko, Yoo‐Joung, Abou‐Alfa, Ghassan K.

Hepatology | May 19, 2025 | Volume: 83 | Issue: 3 | Pages: 484-496

10.1097/hep.0000000000001385 | PMID 40384092 Get It

Background and Aims: In the global phase III HIMALAYA study in unresectable HCC, STRIDE significantly improved overall survival (OS) versus sorafenib; durvalumab was noninferior to sorafenib. Immune checkpoint inhibitor studies have shown an association between the occurrence of immune-mediated adverse events (imAEs) and improved OS. We assessed potential associations between the occurrence of imAEs and OS, and temporal patterns of imAEs, in HIMALAYA. Approach and Results: OS in participants who did and did not experience imAEs and the frequency and timing of imAEs were assessed for STRIDE and durvalumab in the safety analysis set of HIMALAYA. imAEs occurred in 139/388 (35.8%) and 64/388 (16.5%) participants with STRIDE and durvalumab, respectively; most were low grade. OS HRs (95% CI) in participants who experienced imAEs versus those who did not were 0.73 (0.56–0.95) for STRIDE and 1.14 (0.82–1.57) for durvalumab. The 36-month OS rate (95% CI) for STRIDE was 36.2% (28.1–46.7) and 27.7% (22.4–34.2) in participants who did and did not experience imAEs, respectively. The most common imAE category with STRIDE was endocrine events (16.5%). Most imAEs occurred ≤3 months after treatment initiation. Conclusions: Participants who experienced imAEs with STRIDE had a numerical improvement in OS versus those who did not, which was not observed for durvalumab. Long-term OS with STRIDE was observed regardless of imAEs. Most imAEs were low grade, manageable, and occurred in the first 3 months after treatment initiation. Results continue to support the benefits of STRIDE in a diverse population that reflects unresectable HCC globally.
Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry
Seheult, Jansen N. , Otteson, Gregory E., Weybright, Matthew J. , Timm, Michael, Han, Wenchao, Horna, Pedro , Olteanu, Horatiu , Shi, Min , Timm, Michael M, Horna, Pedro , Olteanu, Horatiu , Shi, Min , Seheult, Jansen N , Jevremović, Dragan

Cancers | May 19, 2025 | Volume: 17 | Issue: 10 | Pages: 1688

10.3390/cancers17101688 | PMID 40427185 Get It

Background: Flow cytometric detection of minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) is complex, time-consuming, and subject to inter-operator variability. Deep neural networks (DNNs) offer potential for standardization and efficiency improvement, but require rigorous validation and monitoring for safe clinical implementation. Methods: We evaluated a DNN-assisted human-in-the-loop approach for CLL MRD detection. Initial validation included method comparison against manual analysis (n = 240), precision studies, and analytical sensitivity verification. Post-implementation monitoring comprised four components: daily electronic quality control, input data drift detection, error analysis, and attribute acceptance sampling. Laboratory efficiency was assessed through a timing study of 161 cases analyzed by five technologists. Results: Method comparison demonstrated 97.5% concordance with manual analysis for qualitative classification (sensitivity 100%, specificity 95%) and excellent correlation for quantitative assessment (r = 0.99, Deming slope = 0.99). Precision studies confirmed high repeatability and within-laboratory precision across multiple operators. Analytical sensitivity was verified at 0.002% MRD. Post-implementation monitoring identified 2.97% of cases (26/874) with input data drift, primarily high-burden CLL and non-CLL neoplasms. Error analysis showed the DNN alone achieved 97% sensitivity compared to human-in-the-loop-reviewed results, with 13 missed cases (1.5%) showing atypical immunophenotypes. Attribute acceptance sampling confirmed 98.8% of reported negative cases were true negatives. The DNN-assisted workflow reduced average analysis time by 60.3% compared to manual analysis (4.2 ± 2.3 vs. 10.5 ± 5.8 min). Conclusions: The implementation of a DNN-assisted approach for CLL MRD detection in a clinical laboratory provides diagnostic performance equivalent to expert manual analysis while substantially reducing analysis time. Comprehensive performance monitoring ensures ongoing safety and effectiveness in routine clinical practice. This approach provides a model for responsible AI integration in clinical laboratories, balancing automation benefits with expert oversight.
Guidelines Against Discrimination and Bias in Anatomical Research Papers (GDBARP): Recommendations From Anatomical Journal Editors
Takeda, Sén, Sol, Mariano del , Ravi, Kumar Satish , Singh, Vishram, Apaydın, Nihal, Kim, Hee‐Jin , Adds, Philip J. , Loukas, Marios , Tubbs, R. Shane, Del Sol, Mariano , Ravi, Kumar Satish , Apaydin, Nihal , Adds, Philip , Loukas, Marios , Iwanaga, Joe , Walocha, Jerzy Andrzej , Ribatti, Doménico , Moryś, Janusz , Paulsen, Friedrich P. , Duparc, Fabrice

Clinical Anatomy | May 19, 2025 | Volume: 38 | Issue: 5 | Pages: 613-618

10.1002/ca.24293 | PMID 40384060 Get It

ABSTRACTMost discussions about discrimination and bias in anatomical research papers have been limited to terminology relating to race/ethnicity and gender/sex. However, as editors of anatomical journals, the authors of this article have frequently observed broader instances of potential discrimination and bias within anatomical research. These often stem from differences among authors' backgrounds, traditions, cultures, religions, provenance/origins, and workplace affiliations. In view of the limited discourse on this topic, we seek in this article to establish a consensus among editors of anatomical journals and to propose new Guidelines Against Discrimination and Bias in Anatomical Research Papers (GDBARP). We have identified multiple factors that can contribute to discrimination and bias, underscoring the need for greater awareness and proactive measures. It is imperative in anatomical research to respect authors, reviewers, and editors regardless of their background, culture, traditions, sex, ethnicity, language, religion, or ethical perspectives.
Reducing Barriers to Well-Being and Promoting Mental Health Resources Through a Pilot Opt-Out Check-In Program for Medical Residents
Stratton, Kelcey J. , Finta, Mary K. , Scicluna, Victoria M., Uttal, Sarah , Perlman, Rachel

Health Promotion Practice | May 19, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15248399251337027 | PMID 40383974 Get It

Physicians-in-training experience high rates of mental health, burnout, and well-being concerns, yet face many barriers to accessing care. Burnout is associated with poor self-rated health, sleep disturbances, and other health risks. Unfortunately, residents often face barriers to participating in health-promoting activities due to lack of time, perceived stigma, confidentiality concerns, and low awareness of available services. To improve access to health resources, and specifically mental health support, we developed a pilot opt-out well-being check-in program, offered via videoconferencing, at a large academic medical center. Internal medicine and neurology residents ( N = 93) were protected from clinical duties to meet individually with a psychologist. The 45-minute session consisted of a brief assessment, identification of stressors, discussion of well-being goals, and referral to further services as indicated. The study goals were to establish the feasibility of implementing a program-wide intervention, assess resident satisfaction with the intervention, and reduce barriers to mental health and well-being resources. The study authors developed a brief post-session satisfaction survey. Analysis included participation rates and responses to satisfaction survey questions. 64.5% of residents attended the check-in session. Among the 57% who responded to a post-intervention survey, over 90% agreed that the session was valuable, convenient, and recommended program continuation. This health promotion program successfully offered tailored mental health and well-being support within demanding residency training structures. Opt-out programs that minimize barriers to participation are a valuable part of multifaceted workplace well-being initiatives.
Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report
Anderson, Katelyn , Jones, Amie E., Tollefson, Megha M. , Dermatology, Section on, Wright, Teresa L. , Hunt, Raegan , Lauren, Christine T. , Gupta, Deepti , Kenner‐Bell, Brandi, Anderson, Katelyn R, Schoch, Jennifer J. , Dermatology, Section on, Boull, Christina

Pediatrics | May 18, 2025 | Volume: 155 | Issue: 6 | Pages: No page available

10.1542/peds.2025-071812 | PMID 40383540 Get It

Atopic dermatitis affects 20% to 25% of children and has significant impact on quality of life of patients and families. Recent studies of the pathogenesis of AD highlight the interplay between a defective skin barrier, immune dysfunction, and the cutaneous microbiome. Standard of care for AD treatment includes topical corticosteroids for active disease and moisturization to repair the barrier defect. Emerging treatments include dupilumab and Janus kinase (JAK) inhibitors. Reduction of triggers and proactive treatment with topical corticosteroids and/or topical calcineurin inhibitors can reduce flares. Treatment plans should be clear and as simple as possible to maximize adherence.
The role of computed tomography and endoscopy in caustic esophageal injury in adults: a systematic review
Bass, Elisa , Jenkins, Jan , Saleeb, Andrew G. , Beamer, Staci E. , Jaroszewski, Dawn E. , Ravanbakhsh, Samine, Benz, Cecilia , Santos, Pedro Reck dos , D’Cunha, Jonathan, Jenkins, John Asher, Reck Dos Santos, Pedro, D'Cunha, Jonathan, Farina, Juan M. , Ravanbakhsh, Samine

Diseases of the Esophagus | May 18, 2025 | Volume: 38 | Issue: 3 | Pages: No page available

10.1093/dote/doaf037 | PMID 40382674 Get It

Summary Caustic esophageal injury can cause severe morbidity and mortality. Despite the need for emergent treatment, individual experience in diagnosis and management can be limited. Computed tomography (CT) has emerged as a promising non-invasive modality for assessing injury severity, but the clinical utility of both CT and endoscopy should be investigated. A systematic review was conducted following PRISMA guidelines. A comprehensive search of the PubMed database identified relevant articles published from January 1, 2000 to December 31, 2023. Inclusion criteria encompassed studies investigating the use of CT and/or endoscopy in diagnosing and managing caustic esophageal injury. Twelve articles were selected from a pool of 931 studies. Findings suggested that CT was superior in diagnostic capability to endoscopy in high-grade injury and stricture formation, but less so for low grade injuries. Diagnostic algorithms incorporating imaging with laboratory studies have emerged in the literature, which are promising pending additional validation. CT can serve as a valuable, non-invasive tool in the initial evaluation of caustic esophageal injury and is postulated to accurately predict both the need for emergent surgery and the risk of stricture formation. However, CT should not replace but rather complement the use of endoscopy to comprehensively evaluate these potentially highly morbid situations.
Improving proteomic dynamic range with Multiple Accumulation Precursor Mass Spectrometry (MAP-MS)
Phlairaharn, Teeradon , Shannon, Ariana E. , Zeng, Xinlei, Truong, Dong‐Jiunn Jeffery , Schoof, Erwin M. , Ye, Zilu , Searle, Brian C. , Searle, Brian C , Zeng, Xinlei

No container title available | May 17, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.14.653938 | PMID 40463250 Get It

ABSTRACT Orbitrap (OT) -based mass spectrometer platforms are a gold standard in high-resolution mass spectrometry, where their primary disadvantage is slower-scanning speed in comparison to time-of-flight or linear ion trap mass analyzers. In this study, we utilize long OT transients to extend the precursor dynamic range by modifying the selected ion monitoring method to multiplex several precursor m/z ranges from 400 to 1000 m/z into a single scan called “ M ultiple A ccumulation P recursor M ass S pectrometry” (MAP-MS). Our approach requires no software or hardware modifications and hides the additional ion accumulation steps during the time it takes to make other Orbitrap measurements, producing precursor spectra with nearly 2× dynamic range and essentially no consequences. We collected data using both data-dependent acquisition (DDA) and data-independent acquisition (DIA) methods to evaluate a range of approaches. With DDA, MAP-MS precursor quantification improves with higher quality measurements. At the same time, DIA detection is enhanced by up to 11% when combining precursor and tandem mass spectra for peptide detection.